Stockscreener 앱 받기
0.3621
2.15%
-0.0058
전일 마감가:
$0.3679
열려 있는:
$0.3625
하루 거래량:
17,668
Relative Volume:
0.10
시가총액:
$12.46M
수익:
$7.11M
순이익/손실:
$-41.28M
주가수익비율:
-0.2624
EPS:
-1.38
순현금흐름:
$-26.84M
1주 성능:
-2.99%
1개월 성능:
+15.90%
6개월 성능:
-70.25%
1년 성능:
-70.25%
1일 변동 폭
$0.3522
$0.37
1주일 범위
$0.33
$0.39
52주 변동 폭
$0.2801
$2.2299
Co Diagnostics Inc Stock (CODX) Company Profile
명칭
Co Diagnostics Inc
전화
(801) 278-9769
주소
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
CODX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.362 | 12.46M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
132.43 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.41 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
381.26 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.69 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.44 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-12 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2021-12-29 | 개시 | Sidoti | Buy |
| 2021-03-29 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-05-20 | 업그레이드 | Maxim Group | Hold → Buy |
| 2020-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
Co Diagnostics Inc 주식(CODX)의 최신 뉴스
Co-Diagnostics (NASDAQ:CODX) Stock Rating Upgraded by D Boral Capital - Defense World
D. Boral Capital Initiates Coverage of Co-Diagnostics (LSE:0A50) with Buy Recommendation - Nasdaq
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Relea - GuruFocus
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast - GlobeNewswire
Co-Diagnostics Q1 2025 Earnings Coming May 8: Key Executive Team to Present Latest Financial Performance - Stock Titan
Stock Market Recap: Co-Diagnostics Inc (CODX) Concludes at 0.32, a -18.26 Surge/Decline - DWinneX
Co-Diagnostics (NASDAQ:CODX) Now Covered by Analysts at D. Boral Capital - Defense World
Co-Diagnostics expands sales agreement, adds Clear Street as agent By Investing.com - Investing.com Canada
Co-Diagnostics expands sales agreement, adds Clear Street as agent - Investing.com Australia
This Kohl's Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Benzinga
D. Boral Capital Initiates Coverage of Co-Diagnostics (CODX) with Buy Recommendation - Nasdaq
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. - Seeking Alpha
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results - Seeking Alpha
Co-Diagnostics Inc (NASDAQ: CODX): Is This The Time To Buy? - Marketing Sentinel
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges - Investing.com Canada
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges By Investing.com - Investing.com South Africa
All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy - Yahoo Finance
Co-Diagnostics targets 2025 clinical evaluations for TB and HPV tests in India and South Africa - MSN
Co-Diagnostics Earnings Call: Progress Amid Challenges - MSN
HC Wainwright Lowers Co-Diagnostics (NASDAQ:CODX) Price Target to $1.00 - Defense World
Co-Diagnostics, Inc. (CODX) Reports Q4 Loss, Misses Revenue Estimates - MSN
Co-Diagnostics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Co-Diagnostics sees revenue dip, losses deepen in Q4 2024 By Investing.com - Investing.com South Africa
Co-Diagnostics operating loss hits USD 40.1M in FY 24 - Medical Buyer
Co-Diagnostics Inc (CODX) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Co-Diagnostics Inc (CODX) Q4 2024 Earnings Call Highlights: Navi - GuruFocus
Co-Diagnostics Inc (CODX) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Co-Diagnostics Reports 2024 Financial Results and Strategic Progress - TipRanks
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results - Lelezard
Co-Diagnostics Inc Reports $3.9 Million Revenue and $1.24 EPS Lo - GuruFocus
Co-Diagnostics earnings missed by $0.03, revenue fell short of estimates - Investing.com
Co-Diagnostics (CODX) Highlights 2024 Earnings and Strategic Dev - GuruFocus
Earnings call transcript: Co-Diagnostics sees revenue dip, losses deepen in Q4 2024 - Investing.com India
Co-Diagnostics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results – Company Announcement - Financial Times
Uncovering Potential: Co-Diagnostics's Earnings Preview - Benzinga
Co-Diagnostics stock hits 52-week low at $0.43 amid market challenges - Investing.com Australia
Co-Diagnostics stock hits 52-week low at $0.43 amid market challenges By Investing.com - Investing.com South Africa
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Co-Diagnostics, Inc. Investors of Important Deadline in Securities Class Action – CODX - Business Wire
Co-Diagnostics (CODX) Projected to Post Earnings on Thursday - The AM Reporter
Litigators of the Week: Summary Judgment Win For COVID Test Maker in Securities Fraud Suit Targeting Accuracy Claims - Law.com
Co-Diagnostics stock hits 52-week low at $0.45 amid market challenges - Investing.com Australia
Co Diagnostics Inc (CODX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
9.59%
0.04%
자본화:
|
볼륨(24시간):